Table 1.

Clinical and imaging data

Demographic Data	General Cohort (n = 79)	SMO (n = 22)	AKT1 (n = 12)	Others (n = 45)	P
Sex
Male	17 (21%)	4 (18%)	2 (16%)	11 (25%)	.76
Female	62 (79%)	18 (82%)	10 (84%)	34 (75%)
Age, y
Median	55	55	56	55	.94
Range	22–83	22–72	30–75	26–83
Median preoperative KPS	90	90	80	90	.95
Median FU (mo)	70	83	60	72	.18
Presenting symptoms
Headache	46 (58%)	12 (54%)	6 (50%)	28 (62%)	.68
Visual impairment	33 (41%)	13 (59%)	3 (25%)	17 (38%)	.11
Anosmia	56 (71%)	20 (91%)	7 (58%)	29 (64%)	.04
Cognitive impairment	38 (48%)	13 (59%)	5 (42%)	20 (45%)	.47
Seizures	4 (5%)	2 (9%)	1 (8%)	1 (2%)	.41
Imaging data
Size
Mean tumor diameter (mm)	59	63	54	51	.28
Range	30–90	35–80	30–90	30–70
Hyperostotic bone	52 (66%)	17 (77%)	6 (50%)	29 (65%)	.26